Home / Market News / $KAPA

$KAPA news and market catalysts

The 5 most recent market catalysts affecting $KAPA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

5 catalysts 2 high impact 3 bullish 0 bearish Mining
Nov 9, 2026 Corporate Catalyst Neutral Impact 55
Kapa Gold Initiates Geophysical Program at Blackhawk Gold Project
Kapa Gold Inc. announced the commencement of a geophysical program at its Blackhawk Gold Project. This program, utilizing Induced Polarization and Mobile Metal Ions surveys, aims t…
Oct 6, 2026 Corporate Catalyst Bullish Impact 85
Kairos Pharma Targets Drug Resistance Mechanism Against Prostate Cancer
Kairos Pharma reported highly promising interim efficacy results for its drug candidate ENV-105, demonstrating a median progression-free survival of 17.7 months compared to 2 month…
Aug 21, 2026 Corporate Catalyst Neutral Impact 65
Kairos Pharma Announces 1-For-7 Reverse Stock Split, Effective Sept. 1
Kairos Pharma announced a 1-for-7 reverse stock split, which will consolidate existing shares into fewer, higher-priced shares. This move is often undertaken by companies whose sto…
Jul 22, 2026 Corporate Catalyst Bullish Impact 75
Kairos Pharma Partners With Bayer To Mull ENV-105 Inhibitor In Combination With Bayer’s XOFIGO
Kairos Pharma (KAPA) has entered a strategic collaboration with Bayer to evaluate its lead antibody, ENV-105, in combination with Bayer's XOFIGO for metastatic castration-resistant…
Jul 16, 2026 Corporate Catalyst Bullish Impact 85
Kairos Pharma (KAPA) Stock Surges Over 22% After Hours: Why is it Moving?
Kairos Pharma (KAPA) reported that its lead cancer drug, ENV-105, showed a clean safety profile in a Phase 1 trial, with no serious adverse events among 13 patients. This is a cruc…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.